It's not just that the PSA didn't go down along with tumor and bone responses, it's that it actually skyrocketed (typically doubled or more). In all other prostate treatments I am aware of (except for Dendreon's) PSA was tightly linked to improvement.
I have no idea what this means, but I'll take actual improvement in tumors, mets and pain over a biomarker any day.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.